Profile data is unavailable for this security.
About the company
Seer, Inc. is a life sciences company. The Company is engaged in developing transformative products that open a new gateway to the proteome. Its product, the Proteograph Product Suite (Proteograph), leverages its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access to the proteome. The Proteograph Product Suite is an integrated solution that includes consumables, an automation instrument and software. Its proprietary engineered NPs provide unbiased sampling of intact proteins across the dynamic range of the proteome, capturing molecular information at the peptide-level, including protein variants. It is focused on driving the adoption of the Proteograph by customers in the proteomics and genomics markets. The Proteograph Product Suite is an integrated solution consisting of consumables, an automation instrument, and software to perform biased, deep proteomic analysis at scale in a matter of hours.
- Revenue in USD (TTM)16.66m
- Net income in USD-86.28m
- Incorporated2017
- Employees147.00
- LocationSeer Inc3800 Bridge Parkway, Suite 102REDWOOD CITY 94065United StatesUSA
- Phone+1 (650) 453-0000
- Fax+1 (302) 655-5049
- Websitehttps://seer.bio/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Midwest Energy Emissions Corp | 17.94m | 5.90m | 72.59m | 9.00 | 15.11 | -- | 11.86 | 4.05 | 0.051 | 0.051 | 0.1841 | -0.0083 | 0.9748 | 13.63 | 7.16 | 1,993,376.00 | 32.08 | -21.65 | 37.61 | -47.81 | 32.15 | 32.80 | 32.91 | -15.57 | 10.70 | -6.19 | 1.08 | -- | -17.02 | 7.85 | 473.32 | -- | -- | -- |
| Luna Innovations Inc | 116.61m | -1.12m | 75.90m | 337.00 | -- | 0.8018 | 17.15 | 0.6508 | -0.0339 | -0.0637 | 3.45 | 2.79 | 0.7515 | 1.26 | 2.84 | 346,035.60 | -0.7231 | 0.8556 | -0.9292 | 1.09 | 59.00 | 56.43 | -0.9622 | 1.23 | 1.62 | 0.1366 | 0.2521 | 0.00 | 25.12 | 27.05 | -111.20 | -- | 16.38 | -- |
| Babcock & Wilcox Enterprises Inc | 999.35m | -93.73m | 93.95m | 2.20k | -- | -- | -- | 0.094 | -1.05 | -2.38 | 11.22 | -2.25 | 1.16 | 7.16 | 5.30 | 454,251.80 | -9.16 | -5.50 | -15.81 | -11.87 | 22.42 | 22.90 | -7.87 | -5.30 | 1.10 | 0.5061 | 1.97 | -- | 17.86 | -1.22 | -201.13 | -- | 12.36 | -- |
| Seer Inc | 16.66m | -86.28m | 137.32m | 147.00 | -- | 0.3434 | -- | 8.24 | -1.35 | -1.35 | 0.2609 | 6.17 | 0.0361 | 1.79 | 2.43 | 113,340.10 | -18.67 | -16.65 | -19.21 | -17.09 | 51.05 | -- | -517.84 | -756.71 | 24.66 | -- | 0.00 | -- | 7.54 | -- | 7.20 | -- | 112.67 | -- |
| Geospace Technologies Corp | 143.43m | 24.98m | 158.21m | 681.00 | 6.36 | 1.08 | 3.86 | 1.10 | 1.87 | 1.87 | 10.76 | 10.99 | 0.938 | 3.76 | 4.35 | 210,619.70 | 16.34 | -5.10 | 18.55 | -5.54 | 44.20 | 28.70 | 17.42 | -8.96 | 3.79 | -- | 0.00 | -- | 39.50 | 10.45 | 153.40 | -- | 11.01 | -- |
| Harvard Bioscience, Inc. | 112.25m | -3.42m | 165.87m | 391.00 | -- | 2.27 | 46.29 | 1.48 | -0.0803 | -0.0803 | 2.63 | 1.68 | 0.7941 | 1.81 | 6.84 | 287,084.40 | -2.42 | -3.29 | -2.93 | -3.89 | 58.86 | 56.67 | -3.04 | -4.57 | 0.9164 | 0.4485 | 0.3335 | -- | -0.9573 | -1.45 | 64.11 | -- | 18.10 | -- |
| Northern Technologies International Corp | 82.70m | 3.66m | 166.87m | 86.00 | 46.93 | 2.44 | 24.40 | 2.02 | 0.3772 | 0.3772 | 8.61 | 7.25 | 0.9537 | 3.76 | 5.27 | 961,669.60 | 5.88 | 6.29 | 7.44 | 7.71 | 37.01 | 33.21 | 6.16 | 7.42 | 1.86 | -- | 0.0524 | 53.37 | 7.75 | 9.21 | -53.95 | -16.87 | 34.39 | 13.30 |
| Virtra Inc | 38.04m | 8.40m | 178.53m | 112.00 | 21.00 | 4.19 | 19.13 | 4.69 | 0.7653 | 0.7653 | 3.47 | 3.84 | 0.6163 | 1.03 | 2.78 | 339,672.80 | 13.61 | 7.69 | 17.16 | 9.70 | 70.09 | 59.06 | 22.09 | 11.12 | 2.32 | -- | 0.1587 | -- | 34.42 | 16.04 | 329.62 | 59.34 | 30.96 | -- |
| 908 Devices Inc. | 50.23m | -36.40m | 186.93m | 230.00 | -- | 1.12 | -- | 3.72 | -1.13 | -1.13 | 1.56 | 5.09 | 0.2255 | 1.81 | 5.28 | 218,387.00 | -16.34 | -14.16 | -18.03 | -15.35 | 50.41 | 53.02 | -72.47 | -64.25 | 7.04 | -- | 0.00 | -- | 7.21 | 17.89 | -8.45 | -- | 22.98 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Invus Public Equities Advisors LLCas of 31 Dec 2023 | 4.75m | 7.82% |
| Fidelity Management & Research Co. LLCas of 31 Dec 2023 | 4.11m | 6.76% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 4.06m | 6.69% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 2.57m | 4.23% |
| Capital Research & Management Co. (World Investors)as of 31 Dec 2023 | 2.06m | 3.39% |
| Millennium Management LLCas of 31 Dec 2023 | 1.39m | 2.28% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 1.14m | 1.88% |
| Geode Capital Management LLCas of 31 Dec 2023 | 1.06m | 1.75% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 768.60k | 1.27% |
| BlackRock Advisors LLCas of 31 Dec 2023 | 686.30k | 1.13% |
